Effects of drugs on glucose measurements with handheld glucose meters and a portable glucose analyzer

American Journal of Clinical Pathology

Volumn 113, Issue 1, 2000, Pages 75-86

  Tang, Zuping ^a   Du, Xiaogu ^a   Louie, Richard F ^a   Kost, Gerald J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Compensatory electrode; Critical care; Diabetes mellitus; Drug interference; Electrochemical biosensor; Glucose dehydrogenase; Glucose oxidase; Glucose test strips; Reflectance photometric; Whole blood analysis

Indexed keywords

ACETYLSALICYLIC ACID; ADRENALIN; AMINOPHYLLINE; AMPICILLIN; ASCORBIC ACID; CEFAZOLIN; CIMETIDINE; DEXAMETHASONE; DIGOXIN; DOBUTAMINE; DOPAMINE; ERYTHROMYCIN; FUROSEMIDE; GENTAMICIN; GLIPIZIDE; GLUCOSE; GLYCERYL TRINITRATE; HEPARIN; HYDRALAZINE; INSULIN; LIDOCAINE; MANNITOL; NITROPRUSSIDE SODIUM; NORADRENALIN; PARACETAMOL; PENICILLIN G POTASSIUM; PHENTOLAMINE; PHENYTOIN; PROCAINAMIDE; QUINIDINE; UNINDEXED DRUG; WARFARIN;

ANALYZER; ARTICLE; CLINICAL LABORATORY; CONTROLLED STUDY; CRITICAL ILLNESS; DEVICE; DIABETES MELLITUS; DRUG COMPETITION; DRUG DETERMINATION; ELECTROCHEMISTRY; GLUCOSE ASSAY; GLUCOSE HOMEOSTASIS; PRIORITY JOURNAL; REFLECTOMETRY;

EID: 0034005547     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/qaw1-x5xw-bvrq-5lkq     Document Type: Article

References (57)

1. Maser RE, Butler MA, DeCherney GS. Use of arterial blood with bedside glucose reflectance meters in an intensive care unit: are they accurate? Crit Care Med. 1994;22:595-599.
2. Atkin SH, Dasmahapatra A, Jaker MA, et al. Fingerstick glucose determination in shock. Ann Intern Med. 1991;14:1020-1024.
3. Sylvain HF, Pokorny ME, English SM, et al. Accuracy of fingerstick glucose values in shock patients. Am J Crit Care. 1995;4:44-48.
4. Walker EA, Paduano DJ, Shamoon H. Quality assurance for blood glucose monitoring in health care facilities. Diabetes Care. 1991;14:1043-1049.
5. Bickford GR. Decentralized testing in the 1990s: a survey of United States hospitals. Clin Lab Med. 1994;14:623-645.
6. Kost GJ, Vu HT, Lee JH, et al. Multicenter study of oxygen-insensitive handheld glucose point-of-care testing in critical care/hospital/ambulatory patients in the United States and Canada. Crit Care Med. 1998;26:581-590.
7. Steinberg C, Notterman DA. Pharmacokinetics of cardiovascular drugs in children: inotropes and vasopressors. Clin Pharmacokinet. 1994;27:345-367.
8. Hardman JG, Limbird LE, Molinoff PB, et al. Goodman & Gilman's the Pharmacological Basis of Therapeutics. 9th ed. New York, NY: McGraw-Hill; 1996:1570-1571.
9. Zaloga GP, Macgregor D. The Critical Care Drug Handbook. 2nd ed. St Louis, MO: Mosby-Year Book; 1997.
10. Powers DM, Boyd JC, Glick MR, et al. Interference Testing in Clinical Chemistry. Proposed Guideline. Villanova, PA: National Committee for Clinical Laboratory Standards; 1986. NCCLS publication EP7-P.
11. IFCC Guidelines to the Evaluation of Drug Effects in Clinical Chemistry. Scand J Clin Lab Invest Suppl. 1989;49:1-29.
12. Hirsch IB, Brunzell J, Paauw DS. Inpatient management of adults with diabetes. Diabetes Care. 1995;18:870-878.
13. Queale WS, Seidler AJ, Brancati FL. Glycemic control and sliding scale insulin use in medical inpatients with diabetes mellitus. Arch Intern Med. 1997;157:545-552.
14. Siest G, Appel W, Blijenberg GB, et al. Drug interference in clinical chemistry: studies on ascorbic acid. J Clin Chem Clin Biochem. 1978;16:103-110.
15. Moatti-Sirat D, Velho G, Reach G. Evaluating in vitro and in vivo the interference of ascorbate and acetaminophen on glucose detection by a needle-type glucose sensor. Biosens Bioelectron. 1992;7:345-352.
16. Rice GK, Galt KA. In vitro drug interference with home blood-glucose-measurement systems. Am J Hosp Pharm. 1985;42:2202-2207.
17. Ashworth L, Gibb I, Alberti KG. Hemocue: evaluation of a portable photometric system for determining glucose in whole blood. Clin Chem. 1992;38:1479-1482.
18. White-Stevens RH. Interference by ascorbic acid in test systems involving peroxidase, I: reversible indicators and the effects of copper, iron, and mercury. Clin Chem. 1982;28:578-588.
19. Lindh M, Lindgren K, Carlström A, et al. Electrochemical interferences with the YSI glucose analyzer [letter]. Clin Chem. 1982;28:726.
20. Kaufmann-Raab I, Jonen HG, Jähnchen E, et al. Interference by acetaminophen in the glucose oxidase-peroxidase method for blood glucose determination. Clin Chem. 1976;22:1729-1731.
21. Lewis BD. Laboratory evaluation of the Glucocard™ blood glucose test meter. Clin Chem. 1992;38:2093-2095.
22. Mayer M, Salpeter L. Toxic levels of acetaminophen produce a major positive interference on Glucometer Elite and Accu-chek Advantage glucose meters [letter]. Clin Chem. 1998;44:893-894.
23. Keeling AB, Schmidt P. Dopamine influence on whole-blood glucose reagent strips [letter]. Diabetes Care. 1987;10:532.
24. Thea J, Moore G, Gina Nam, et al. Chemically amplified voltammetric enzyme electrodes for oxidizable pharmaceuticals. Anal Chem. 1994;66:3158-3163.
25. Nguyen T, Tang Z, Kost GJ. In vitro drug interference with glucose and lactate measurements obtained with the three-layer membrane electrochemical biosensors. Presented at: Oakridge Conference, American Association of Clinical Chemistry, San Jose, CA, April 23-24, 1999.
26. Cameron E, Campbell A, Jack T. The orthomolecular treatment of cancer, III: reticulum cell sarcoma: double complete regression induced by high-dose ascorbic acid therapy. Chem Biol Interact. 1975;11:387-393.
27. Hoffer A. Ascorbic acid and toxicity [letter]. N Engl J Med. 1971;9:635-636.
28. Badrick TC, Campbell B. Effects of intravenous infusion of ascorbic acid on common clinical chemistry tests [letter]. Clin Chem. 1992;38:2160.
29. Luberoff BJ. Symtomectomy: a chat with Robert Cathcart, MD. Chemtech. February 1978:76-86.
30. Eriksson J, Kohvakka A. Magnesium and ascorbic acid supplementation in diabetes mellitus. Ann Nutr Metab. 1995;39:217-223
31. Grant JP. Nutritional support in critically ill patients. Ann Surg. 1994;220:610-616.
32. Schorah CJ, Downing C, Piripitsi A, et al. Total vitamin C, ascorbic acid, and dehydroascorbic acid concentrations in plasma of critically ill patients. Am J Clin Nutr. 1996; 63:760-765.
33. Cameron E, Campbell A. The orthomolecular treatment of cancer, II: clinical trial of high-dose ascorbic acid supplements in advanced human cancer. Chem Biol Interact. 1974;9:285-315.
34. Breuer J. Report on the symposium "Drug Effects in Clinical Chemistry Methods." Eur J Clin Chem Clin Biochem. 1996;34:385-386.
35. Sylvester EC, Price CP, Burrin JM. Investigation of the potential for interference with whole blood glucose strips. Ann Clin Biochem. 1994;31:94-96.
36. Sporer KA, Khayam-Bashi H. Acetaminophen and salicylate serum levels in patients with suicidal ingestion or altered mental status. Am J Emerg Med. 1996;14:443-446.
37. Kumar A, Goel KM, Rae, MD. Paracetamol overdose in children. Scott Med J. 1990;35:106-110.
38. Buchanan PA, Buchanan N. Paracetamol poisoning in children and hepatotoxicity. Br J Clin Pharmacol. 1991;32:143-149.
39. Arena JM, Drew RH. Poisoning: Toxicology, Symptoms, Treatments. Springfield, IL: Charles C. Thomas; 1986.
40. Cartier LJ, Leclerc P, Pouliot M, et al. Toxic levels of acetaminophen produce a major positive interference on Glucometer Elite and Accuchek Advantage Glucose Meters [letter]. Clin Chem. 1998;44:893-894.
41. Copland AM, Mather J, Ness A, et al. Apparent hyperglycaemia in paracetamol overdose [letter]. Br J Gen Pract. 1992;259-260.
42. Roddis MJ. Paracetamol interference with glucose analysis. Lancet. 1981;19:634-635.
43. Farah D A, Boag D, Moran F, et al. Paracetamol interference with blood glucose analysis: a potentially fatal phenomenon. Br Med J (Clin Res Ed). 1982;285:172.
44. D'Orazio P, Parker R. Interference by the oxidizable pharmaceuticals acetaminophen and dopamine at electrochemical biosensors for blood glucose [abstract]. Clin Chem. 1995;41(suppl):S156.
45. Pavoni V, Verri M, Ferraro L, et al. Plasma dopamine concentration and effects of low dopamine doses on urinary output after major vascular surgery. Kidney Int Suppl. 1998;53:S75-S80.
46. Kalman S, Berg S, Lisander B. Combined overdose with verapamil and atenolol: treatment with high doses of adrenergic agonists. Acta Anaesthesiol Scand. 1998; 42:379-382.
47. Notterman DA, Greenwald BM, Moran F, et al. Dopamine clearance in critically ill infants and children: effect of age and organ system dysfunction. Clin Pharmacol Ther. 1990;48:138-147.
48. Zaritsky A, Lotze A, Stull R, et al. Steady-state dopamine clearance in critically ill infants and children. Crit Care Med. 1988;16:217-220.
49. Ting C, Nanji AA. Evaluation of the quality of bedside monitoring of the blood glucose level in a teaching hospital. CMAJ. 1988;138:23-26.
50. Nissenson AR, Weston RE, Kleeman CR. Mannitol. West J Med. 1979;131:277-284.
51. Tryding N, Tufvesson C, Sonntag O. Drug Effects in Clinical Chemistry 1996. 7th ed. Stockholm, Sweden: Apoteksbolaget AB; 1996:22-23.
52. Dorman HR, Sondheimer JH, Cadnapaphornchai P. Mannitol-induced acute renal failure. Medicine. 1990;69:153-159.
53. Rabetoy GM, Fredericks MR, Hostettler CF. Where the kidney is concerned, how much mannitol is too much? Ann Pharmacother. 1993;27:25-28.
54. Weaver A, Sica DA. Mannitol-induced acute renal failure. Nephron. 1987;45:233-235.
55. Whelan TV, Bacon ME, Madden M, et al. Acute renal failure associated with mannitol intoxication. Arch Intern Med. 1984;144:2053-2055.
56. Goldwasser P, Fotino S. Acute renal failure following massive mannitol infusion. Arch Intern Med. 1984; 144:2214-2216.
57. Rello J, Triginer C, Sánchez AN, et al. Acute renal failure following massive mannitol infusion. Nephron. 1989; 53:377-378.